21 Sep 2018 | 2:55 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
669.40
-11.70
(-1.71 %)
19 Sep 2018 | 03:57 PM
Change company
  • Open (Rs)
    687.80
  • Prev. close (Rs.)
    681.10
  • High (Rs.)
    687.80
  • Low (Rs.)
    666.15
  • 52W H (Rs.)
    704.65
  • 52W L (Rs.)
    483.60
  • Volume
    63983
  • MCap (Rs in Cr.)
    18,888.33
673.95
-6.10
(-0.90 %)
  • Open (Rs)
    685.90
  • High (Rs)
    688.20
  • Low (Rs)
    667.40
  • Prev. close(Rs)
    680.05
  • Contracts Tra.
    18,84,000
  • Turnover (Cr.)
    128
  • Open Interest
    35,69,000
  • Open Int. chg
    1,11,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
28.49
Operating Margin (%)
17.80
Gross Profit Margin (%)
14.47
Net Profit Margin (%)
8.85
Total Debt/Equity
0.86
Dividend payout Ratio (Net Profit)
8.44
Earning Retention Ratio
91.56

News

17 Sep 2018 - 11:18:00-Glenmark Pharmaceuticals Inc...
10 Sep 2018 - 09:26:00-Glenmark Pharmaceuticals Ltd a research-led global integrated pharmaceutical companyhas said that it...
29 Aug 2018 - 13:56:00-Glenmark Pharmaceuticals Europe has entered into a strategic exclusive licensing agreement for marke...
08 Aug 2018 - 10:00:00-Glenmark Pharmaceuticals a global pharmaceutical company has said that the U.S...

Announcements

19-Sep-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
19-Sep-2018
Glenmark Pharma - Press Release
17-Sep-2018
Glenmark Pharma - Press Release
17-Sep-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
10-Sep-2018
Glenmark Pharma - Press Release

Religare Research

19 Sep 2018 | 10:30 AM
Daily Techno Funda
19 Sep 2018 | 10:15 AM
The rupee, Asia's worst-performing currency in 2018, fell to an all-time low of 72.99 to dollar befo...
19 Sep 2018 | 09:57 AM
Highlights: Bullish trend returned for the Agri markets. An 8% deficiency in Monsoon is keeping ap...
19 Sep 2018 | 07:00 AM
We may see some pause in Nifty after the recent fall but the bias would remain on the negative sides...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 73.52 -0.34
10,00,000 115.06 62.19 -0.34
10,00,000 115.06 205.39 -0.34
10,00,000 115.06 215.10 -0.33
10,00,000 115.06 77.79 -0.33

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI4.01%
FI/Banks2.94%
Insurance2.94%
FII30.61%
Government0.00%
Others5.21%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
8,330.00(-1.14)
3280
 Sanofi India Ltd.
6,350.00(-1.18)
3325
 Pfizer Ltd.
3,113.15(-5.97)
3370
 Piramal Enterprises Ltd.
2,910.00(-0.66)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.61.6083.30126.20
NIFTY(S&P CNX)-317.40523.901,140.10
BSE SENSEX-1,157.531,834.484,198.10
BSE 500-466.86489.981,037.92

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda